Future studies could further explore the specific mechanisms of action of stomatin through lipid metabolic pathways in DLBCL, as well as evaluate the efficacy and safety of stomatin-based anticancer therapeutic strategies. This evidence concerns the gene STOM and diffuse large B-cell lymphoma.